ClinConnect ClinConnect Logo
Search / Trial NCT04754607

Effects of Low-Level Laser Therapy on Oxidative Stress Levels

Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Feb 12, 2021

Trial Information

Current as of June 09, 2025

Completed

Keywords

Hashimoto Thyroiditis Oxidative Stress Low Level Laser Therapy Quality Of Life Autoimmune Thyroiditis Thyroid Hormones Photobiomodulation Therapy

ClinConnect Summary

Hashimoto's thyroiditis (HT) is the most commonly observed inflammatory and autoimmune disease of the thyroid gland. HT is the main cause of spontaneous hypothyroidism in adults. Symptoms of hypothyroidism may develop within a few years in patients with initial euthyroidism. Many genetic and environmental factors play a role in the pathogenesis of the disease, including iodine exposure, drugs, chemicals, toxins, infections and smoking. In recent years, the relationship between oxidative stress level and thyroid autoantibodies in HT has attracted increasing attention of researchers. In the s...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Cases between the ages of 18-65 who applied to the Kosuyolu Istanbul Medipol Hospital Endocrinology and Metabolic Diseases Clinic between 2020-2021 and diagnosed as "Hashimoto Thyroiditis" by a specialist physician will be included in the study.
  • Exclusion Criteria:
  • Acute infection
  • Use of immunosuppressants, immunostimulants and drugs that interfere with the production, transport, and metabolism of thyroid hormones
  • Thyroid nodules
  • Tracheal stenosis
  • Serious illness
  • History of exposure to ionizing radiation and/or neoplasia in the cervical region
  • Malignancy and a history of thyroid surgery
  • Hypothyrodism caused by postpartum thyroiditis
  • Pregnancy and breastfeeding period
  • Identification and diagnosis of the cases with neurological and psychiatric disorders.

About Istanbul Medipol University Hospital

Istanbul Medipol University Hospital is a leading healthcare institution in Turkey, renowned for its commitment to advanced medical research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate innovative studies across various medical fields. With a strong emphasis on patient safety and ethical standards, Istanbul Medipol University Hospital strives to contribute to the advancement of medical knowledge and the development of effective treatments, ensuring high-quality care and improved health outcomes for patients.

Locations

Istanbul, , Turkey

Istanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Şükriye Leyla ALTUNTAŞ

Study Director

Medipol University

Murat ATMACA

Study Chair

Medipol University

Sümeyye TUNÇ

Principal Investigator

Medipol University

Çağrı ÇAKICI

Study Chair

Medipol University

Türkan YİĞİTBAŞI

Study Chair

Medipol University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials